ArticleBiomimetics (Basel, Switzerland)2025
Task-Related EEG as a Biomarker for Preclinical Alzheimer's Disease: An Explainable Deep Learning Approach.
Article in Biomimetics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- QuantumNeuroXAI: a quantum-inspired deep learning framework with explainability for brain signal analysis and neurological disorder detection.Scientific reports · 2026Article
- Advances in Brain-Computer Interfaces (BCI): Challenges and Opportunities.Biomimetics (Basel, Switzerland) · 2026Article
- EEGDecoder-x: an explainable deep learning framework for cross-subject EEG-based detection of Alzheimer's and Creutzfeldt-Jakob disease.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The early detection of Alzheimer's disease (AD) in cognitively healthy individuals remains a major preclinical challenge. EEG is a promising tool that has shown effectiveness in detecting AD risk. Task-related EEG has been rarely used in Alzheimer's disease research, as most studies have focused on resting-state EEG. An interpretable deep learning framework-Interpretable Convolutional Neural Network (InterpretableCNN)-was utilized to identify AD-related EEG features. EEG data were recorded during three cognitive task conditions, and samples were labeled based on APOE genotype and polygenic risk scores. A 100-fold leave-p%-subjects-out cross-validation (LPSO-CV) was used to evaluate model performance and generalizability. The model achieved an ROC AUC of 60.84% across the tasks and subjects, with a Kappa value of 0.22, indicating fair agreement. Interpretation revealed a consistent focus on theta and alpha activity in the parietal and temporal regions-areas commonly associated with AD pathology. Task-related EEG combined with interpretable deep learning can reveal early AD risk signatures in healthy individuals. InterpretableCNN enhances transparency in feature identification, offering a valuable tool for preclinical screening.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.